{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:06:32Z","timestamp":1779019592802,"version":"3.51.4"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004532","name":"Japan International Cooperation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009037","name":"Science and Technology Research Partnership for Sustainable Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.micpath.2026.108503","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:20:47Z","timestamp":1776237647000},"page":"108503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combating antimicrobial-resistant Helicobacter pylori infection using nanotechnology- an advancement in gastrointestinal disease treatment"],"prefix":"10.1016","volume":"216","author":[{"given":"Syed Ali Raza","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzna","family":"Kashif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamshul","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imtiaz","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumaira","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9344-0720","authenticated-orcid":false,"given":"Iffat","family":"Nayila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsa","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108503_bib1","article-title":"New advances in nano-drug delivery systems: helicobacter pylori and gastric cancer","volume":"12","author":"Zhu","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-024-01068-9","article-title":"Targeted nanotherapeutics for the treatment of Helicobacter pylori infection","volume":"31","author":"Chitas","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.micpath.2026.108503_bib3","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14149.1","article-title":"Current understanding and management of Helicobacter pylori infection: an updated appraisal","volume":"7","author":"Ansari","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.micpath.2026.108503_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2022.100129","article-title":"Metallic nanoparticles as promising tools to eradicate H. pylori: a comprehensive review on recent advancements","volume":"6","author":"Asgari","year":"2022","journal-title":"Talanta Open"},{"issue":"12","key":"10.1016\/j.micpath.2026.108503_bib5","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3390\/antibiotics12121669","article-title":"Antibiotic resistance and therapy for Helicobacter pylori infection","volume":"12","author":"Smith","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108503_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s43088-023-00417-1","article-title":"Recent trends in Helicobacter pylori management: harnessing the power of AI and other advanced approaches","volume":"12","author":"Addissouky","year":"2023","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"issue":"10","key":"10.1016\/j.micpath.2026.108503_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14787210.2019.1677464","article-title":"An overview of nanotechnology-based treatment approaches against Helicobacter pylori","volume":"17","author":"Safarov","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.micpath.2026.108503_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00339-024-07440-8","article-title":"Allium hooshidaryae (Alliaceae)-based green-synthesized Fe3O4@MoS2 core\u2013shell nanoparticles coated with chitosan and investigating their biological properties","volume":"130","author":"Abbasi","year":"2024","journal-title":"Appl. Phys. A"},{"key":"10.1016\/j.micpath.2026.108503_bib9","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1038\/s41598-024-56512-5","article-title":"Antifungal activity of Fe3O4@SiO2\/Schif-base\/Cu(II) magnetic nanoparticles against pathogenic candida species","volume":"14","author":"Azadi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108503_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.105095","article-title":"Antimicrobial activity of biosynthesized Cuo\/Se nanocomposite against Helicobacter pylori","volume":"16","author":"Abou Baker","year":"2023","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.micpath.2026.108503_bib11","article-title":"Advances in micro\/nanodrug delivery systems for the treatment of Helicobacter pylori infection: from diagnosis to eradication","volume":"37","author":"Bu","year":"2024","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.micpath.2026.108503_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1081271","article-title":"Application of biomaterials in the eradication of Helicobacter pylori: a bibliometric analysis and overview","volume":"14","author":"Shu","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108503_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1134254","article-title":"A review on the research progress on non-pharmacological therapy of Helicobacter pylori","volume":"14","author":"Luo","year":"2023","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2026.108503_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20406","article-title":"Pylori infection and gastric ulcer: need for novel pharmaceutical formulation","volume":"9","author":"Gupta","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"47","key":"10.1016\/j.micpath.2026.108503_bib16","doi-asserted-by":"crossref","first-page":"14983","DOI":"10.1021\/acs.nanolett.4c03692","article-title":"Antibiotic-augmented chemodynamic therapy for treatment of Helicobacter pylori infection in the dynamic stomach environment","volume":"24","author":"Yan","year":"2024","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/microorganisms12010222","article-title":"Helicobacter pylori: a contemporary perspective on pathogenesis, diagnosis and treatment strategies","volume":"12","author":"Ali","year":"2024","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2120747","article-title":"Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives","volume":"14","author":"Lai","year":"2022","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.micpath.2026.108503_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202302532","article-title":"Future nanotechnology-based strategies for improved management of Helicobacter pylori infection","volume":"20","author":"Kamankesh","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.micpath.2026.108503_bib20","article-title":"Helicobacter pylori infection in Africa: comprehensive insight into its pathogenesis, management, and future perspectives","author":"Emmanuel","year":"2024","journal-title":"J. Umm Al-Qura Univ. Appl. Sci."},{"key":"10.1016\/j.micpath.2026.108503_bib21","first-page":"32","article-title":"Role of nano enzyme in diagnosis, prognosis and treatment of gastrointestinal tract (GIT) cancer: Nano enzymes in diagnosis, prognosis, and treatment of GIT cancer","volume":"1","author":"Shuja","year":"2024","journal-title":"Dev. Medico-Life-Sci."},{"issue":"3","key":"10.1016\/j.micpath.2026.108503_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202302532","article-title":"Future nanotechnology-based strategies for improved management of Helicobacter pylori infection","volume":"20","author":"Kamankesh","year":"2024","journal-title":"Small"},{"issue":"9","key":"10.1016\/j.micpath.2026.108503_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10856-023-06748-w","article-title":"Targeted delivery of a short antimicrobial peptide (CM11) against Helicobacter pylori gastric infection using concanavalin A-coated chitosan nanoparticles","volume":"34","author":"Moosazadeh Moghaddam","year":"2023","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.micpath.2026.108503_bib24","first-page":"54","article-title":"Antimicrobial activity of natural products against Helicobacter pylori: a review","volume":"13","author":"Bonif\u00e1cio","year":"2014","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65762-2","article-title":"Anti-Helicobacter pylori activity of nanocomposites from chitosan\/broccoli mucilage\/selenium nanoparticles","volume":"14","author":"Aborabu","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.micpath.2026.108503_bib26","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.3346\/jkms.2024.39.e44","article-title":"Antibiotic resistance of Helicobacter pylori: mechanisms and clinical implications","volume":"39","author":"Hasanuzzaman","year":"2024","journal-title":"J. Kor. Med. Sci."},{"issue":"5","key":"10.1016\/j.micpath.2026.108503_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5009\/gnl18137","article-title":"Management of antibiotic-resistant Helicobacter pylori infection: perspectives from Vietnam","volume":"13","author":"Khien","year":"2019","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/CM9.0000000000003419","article-title":"Cardiovascular diseases in patients with cancer: a comprehensive review of epidemiological trends, cardiac complications, and prognostic implications","volume":"138","author":"Alshahrani","year":"2025","journal-title":"Chin. Med. J. (Engl)"},{"issue":"12","key":"10.1016\/j.micpath.2026.108503_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/diseases12120311","article-title":"Helicobacter pylori: routes of infection, antimicrobial resistance, and alternative therapies as a means to develop infection control","volume":"12","author":"Elbehiry","year":"2024","journal-title":"Diseases"},{"key":"10.1016\/j.micpath.2026.108503_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1418129","article-title":"Novel therapeutic regimens against Helicobacter pylori: an updated systematic review","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2026.108503_bib31","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/antibiotics9100658","article-title":"Synergistic therapies as a promising option for the treatment of antibiotic-resistant Helicobacter pylori","volume":"9","author":"Krzy\u017cek","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108503_bib32","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2147\/IJN.S405052","article-title":"Metal-based nanoparticles: a prospective strategy for Helicobacter pylori treatment","volume":"18","author":"Yin","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2026.108503_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1330029","article-title":"Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review","volume":"14","author":"Liu","year":"2024","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108503_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2217\/nnm-2019-0329","article-title":"Eradication of Helicobacter pylori: the power of nanosized formulations","volume":"15","author":"Zhang","year":"2020","journal-title":"Nanomedicine (Lond)"},{"issue":"10","key":"10.1016\/j.micpath.2026.108503_bib35","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3390\/microorganisms12101986","article-title":"Opportunities for Helicobacter pylori eradication beyond conventional antibiotics","volume":"12","author":"Savitri","year":"2024","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.micpath.2026.108503_bib36","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/pharmaceutics14071340","article-title":"Scope and limitations of current antibiotic therapies against helicobacter pylori: reviewing amoxicillin gastroretentive formulations","volume":"14","author":"Grosso","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.micpath.2026.108503_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070776","article-title":"The molecular basis of inactivation of metronidazole-resistant Helicobacter pylori using polyethyleneimine functionalized zinc oxide nanoparticles","volume":"8","author":"Chakraborti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108503_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/461034","article-title":"Does long-term use of silver nanoparticles have persistent inhibitory effect on H. pylori based on Mongolian gerbil's model?","volume":"2014","author":"Kuo","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2026.108503_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s11671-015-0747-0","article-title":"Multidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cells","volume":"10","author":"Gurunathan","year":"2015","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.micpath.2026.108503_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.micpath.2017.12.039","article-title":"Green synthesis of anisotropic zinc oxide nanoparticles with antibacterial and cytofriendly properties","volume":"115","author":"Saravanana","year":"2018","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib41","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1038\/s41598-019-42112-1","article-title":"Unveiling the potentials of biocompatible silver nanoparticles on human lung carcinoma A549 cells and Helicobacter pylori","volume":"9","author":"Saravanakumar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108503_bib42","article-title":"Oral pH sensitive GNS@ab nanoprobes for targeted therapy of Helicobacter pylori without disturbance gut microbiome","volume":"20","author":"Zhi","year":"2019","journal-title":"Nanomedicine"},{"issue":"49","key":"10.1016\/j.micpath.2026.108503_bib43","doi-asserted-by":"crossref","first-page":"54316","DOI":"10.1021\/acsami.0c13101","article-title":"Residence time-extended nanoparticles by magnetic field improve the eradication efficiency of Helicobacter pylori","volume":"12","author":"Yang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3897\/folmed.63.e53479","article-title":"Construction of metronidazole capped in gold nanoparticles against Helicobacter pylori: antimicrobial activity improvement","volume":"63","author":"Fateh","year":"2021","journal-title":"Folia Med. (Plovdiv)"},{"issue":"14","key":"10.1016\/j.micpath.2026.108503_bib45","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.3390\/molecules27144559","article-title":"Synergistic effect between amoxicillin and zinc oxide nanoparticles reduced by oak gall extract against Helicobacter pylori","volume":"27","author":"Attia","year":"2022","journal-title":"Molecules"},{"issue":"Pt 6","key":"10.1016\/j.micpath.2026.108503_bib46","article-title":"Evaluation of the in vitro anti-inflammatory and anti-Helicobacter pylori activities of chitosan-based biomaterials modified with copper oxide nanoparticles","volume":"253","author":"Elmehbad","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2026.108503_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1419568","article-title":"Implications of silver nanoparticles for H. pylori infection: modulation of CagA function and signaling","volume":"14","author":"Hochvaldova","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108503_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123655","article-title":"Rubropunctatin-silver composite nanoliposomes for eradicating Helicobacter pylori in vitro and in vivo","volume":"649","author":"Zhao","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2026.108503_bib49","article-title":"How to manage Helicobacter pylori infection beyond antibiotics: the bioengineering quest","volume":"37","author":"Fonseca","year":"2024","journal-title":"Appl. Mater. Today"},{"issue":"18","key":"10.1016\/j.micpath.2026.108503_bib50","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1016\/j.biomaterials.2013.02.028","article-title":"Genipin-cross-linked fucose-chitosan\/heparin nanoparticles for the eradication of Helicobacter pylori","volume":"34","author":"Lin","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.micpath.2026.108503_bib51","first-page":"22","article-title":"Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori. Carbohydr Polym","volume":"109","author":"Pan-In","year":"2014"},{"issue":"5","key":"10.1016\/j.micpath.2026.108503_bib52","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1208\/s12249-015-0443-5","article-title":"Lectin-conjugated clarithromycin and acetohydroxamic acid-loaded PLGA nanoparticles: a novel approach for effective treatment of H. pylori","volume":"17","author":"Jain","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/nnm.14.76","article-title":"Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study","volume":"10","author":"Lin","year":"2015","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib54","first-page":"41","article-title":"Study of antimicrobial effects of clarithromycin loaded PLGA nanoparticles against clinical strains of Helicobacter pylori","volume":"66","author":"Lotfipour","year":"2016","journal-title":"Drug Res."},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib55","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ijpharm.2015.10.065","article-title":"Preparation and evaluation of amoxicillin loaded dual molecularly imprinted nanoparticles for anti-Helicobacter pylori therapy","volume":"496","author":"Wu","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib56","article-title":"Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection","volume":"1","author":"Angsantikul","year":"2018","journal-title":"Adv Ther (Weinh)"},{"key":"10.1016\/j.micpath.2026.108503_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.msec.2017.08.038","article-title":"Development of novel pH-sensitive thiolated chitosan\/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori","volume":"83","author":"Arif","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.micpath.2026.108503_bib58","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijbiomac.2018.04.070","article-title":"Anti-Helicobacter pylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2\/TPP nanoparticles based on ureido-modified chitosan derivative","volume":"115","author":"Jing","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2026.108503_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.colsurfb.2018.01.008","article-title":"Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori","volume":"164","author":"Luo","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.micpath.2026.108503_bib60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2019.02.039","article-title":"Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm","volume":"300","author":"Li","year":"2019","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.micpath.2026.108503_bib61","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.molpharmaceut.9b01264","article-title":"New Silver(I) coordination compound loaded into polymeric nanoparticles as a strategy to improve in vitro anti-helicobacter pylori activity","volume":"17","author":"Almeida Furquim de Camargo","year":"2020","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.micpath.2026.108503_bib62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ajg.2021.06.002","article-title":"Synthesis and characterization of amoxicillin-loaded polymeric nanocapsules as a drug delivery system targeting Helicobacter pylori","volume":"22","author":"Abdelghany","year":"2021","journal-title":"Arab. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.micpath.2026.108503_bib63","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/09205063.2020.1870323","article-title":"Chitosan-based nanoparticles as delivery-carrier for promising antimicrobial glycolipid biosurfactant to improve the eradication rate of Helicobacter pylori biofilm","volume":"32","author":"Arif","year":"2021","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"18","key":"10.1016\/j.micpath.2026.108503_bib64","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1080\/09205063.2021.1972559","article-title":"Bacteria-targeting chitosan\/carbon dots nanocomposite with membrane disruptive properties improve eradication rate of Helicobacter pylori","volume":"32","author":"Arif","year":"2021","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.31557\/APJCP.2022.23.1.61","article-title":"Curcumin encapsulated into biocompatible Co-Polymer PLGA nanoparticle enhanced anti-gastric cancer and anti-Helicobacter Pylori effect","volume":"23","author":"Alam","year":"2022","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.micpath.2026.108503_bib66","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijbiomac.2022.02.039","article-title":"Chitosan-curcumin complexation to develop functionalized nanosystems with enhanced antimicrobial activity against hetero-resistant gastric pathogen","volume":"204","author":"Ejaz","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"15","key":"10.1016\/j.micpath.2026.108503_bib67","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.3390\/polym14152994","article-title":"Molecular docking and efficacy of Aloe vera gel based on chitosan nanoparticles against Helicobacter pylori and its antioxidant and anti-inflammatory activities","volume":"14","author":"Yahya","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.micpath.2026.108503_bib68","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2022.05.044","article-title":"Antibiotics-free nanoparticles eradicate Helicobacter pylori biofilms and intracellular bacteria","volume":"348","author":"Zou","year":"2022","journal-title":"J. Contr. Release"},{"issue":"Pt 2","key":"10.1016\/j.micpath.2026.108503_bib69","article-title":"Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: a novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment","volume":"253","author":"Fayed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.micpath.2026.108503_bib70","doi-asserted-by":"crossref","first-page":"14533","DOI":"10.1021\/acsami.3c18772","article-title":"One-pot microfluidics to engineer chitosan nanoparticles conjugated with antimicrobial peptides using \"Photoclick\" chemistry: validation using the gastric bacterium Helicobacter pylori","volume":"16","author":"Fonseca","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"Pt 2","key":"10.1016\/j.micpath.2026.108503_bib71","article-title":"Synthesis and biological evaluation against H. pylori of chitosan menthone Schiff base hybrid with different types of inorganic nanoparticles","volume":"257","author":"Hamed","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2026.108503_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114280","article-title":"Engineering resveratrol-loaded chitosan nanoparticles for potential use against Helicobacter pylori infection","volume":"199","author":"Sp\u00f3sito","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/j.micpath.2026.108503_bib73","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/1061186X.2013.784978","article-title":"Development and characterization of nanolipobeads-based dual drug delivery system for H. pylori targeting","volume":"21","author":"Jain","year":"2013","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib74","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijpharm.2015.09.055","article-title":"Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro","volume":"495","author":"Cai","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.micpath.2026.108503_bib75","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2017.01.014","article-title":"Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori","volume":"519","author":"Seabra","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2026.108503_bib76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejpb.2018.02.030","article-title":"Lipid nanoparticles to counteract gastric infection without affecting gut microbiota","volume":"127","author":"Seabra","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.micpath.2026.108503_bib77","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2147\/IJN.S193992","article-title":"Delivering amoxicillin at the infection site - a rational design through lipid nanoparticles","volume":"14","author":"Lopes-de-Campos","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2026.108503_bib78","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.2147\/DDDT.S285522","article-title":"Mini-tablets versus nanoparticles for controlling the release of amoxicillin: in vitro\/In vivo study","volume":"14","author":"Gaber","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.micpath.2026.108503_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104896","article-title":"Co-delivery of hesperidin and clarithromycin in a nanostructured lipid carrier for the eradication of Helicobacter pylori in vitro","volume":"112","author":"Sharaf","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.micpath.2026.108503_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112403","article-title":"Experimental design and optimization of a novel dual-release drug delivery system with therapeutic potential against infection with Helicobacter pylori","volume":"213","author":"Arrua","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.micpath.2026.108503_bib81","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41467-024-45156-8","article-title":"A nanoparticle-based sonodynamic therapy reduces Helicobacter pylori infection in mouse without disrupting gut microbiota","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108503_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139746","article-title":"Design, synthesis, and in-Silco ADME prediction of some novel bis(1,3,4-thiadiazoles) encapsulated lipid-chitosan nano capsule decorative with magnetic nanoparticles and their potential anti-helicobacter pylori activity","volume":"296","author":"Salem","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108503_bib83","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/1040841X.2023.2274835","article-title":"Microparticles and nanoparticles-based approaches to improve oral treatment of Helicobacter pylori infection","volume":"50","author":"Paes Dutra","year":"2024","journal-title":"Crit. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108503_bib84","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/1040841X.2021.1975643","article-title":"Helicobacter pylori infection: from standard to alternative treatment strategies","volume":"48","author":"Sousa","year":"2022","journal-title":"Crit. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.micpath.2026.108503_bib85","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/14787210.2024.2391910","article-title":"Unveiling the potential role of micro\/nano biomaterials in the treatment of Helicobacter pylori infection","volume":"22","author":"Fathi","year":"2024","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"4","key":"10.1016\/j.micpath.2026.108503_bib86","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/1040841X.2021.1895721","article-title":"Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections","volume":"47","author":"de Souza","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108503_bib87","first-page":"163","article-title":"Molecular mechanisms of antibiotic resistance and novel treatment strategies for Helicobacter pylori infections","volume":"8","author":"Srisuphanunt","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib88","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/antibiotics12020191","article-title":"Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic and control challenges","volume":"12","author":"Elbehiry","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108503_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122541","article-title":"Overcoming antibiotic resistance caused by genetic mutations of Helicobacter pylori with mucin adhesive polymer-based therapeutics","volume":"308","author":"Lim","year":"2024","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib90","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/1040841X.2024.2364194","article-title":"Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings","volume":"51","author":"Umar","year":"2025","journal-title":"Crit. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.micpath.2026.108503_bib91","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00203-023-03639-0","article-title":"Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents","volume":"205","author":"Al-Fakhrany","year":"2023","journal-title":"Arch. Microbiol."},{"issue":"9","key":"10.1016\/j.micpath.2026.108503_bib92","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/antibiotics10091061","article-title":"The emergence of multidrug-resistant Helicobacter pylori in Southeast Asia: a systematic review on the trends and intervention strategies using antimicrobial peptides","volume":"10","author":"Sukri","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib93","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/pharmaceutics12020142","article-title":"Nanomedicine fight against antibacterial resistance: an overview of the recent pharmaceutical innovations","volume":"12","author":"Eleraky","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib94","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00203-023-03404-3","article-title":"Nanotechnology: a contemporary therapeutic approach in combating infections from multidrug-resistant bacteria","volume":"205","author":"Brar","year":"2023","journal-title":"Arch. Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2026.108503_bib95","first-page":"4","article-title":"The transformative role of nanoenzymes in the diagnosis, targeted treatment, and prognosis of Ovarian Cancer. A comprehensive review: Role of nano enzyme in diagnosis, treatment and prognosis of ovarian cancer","volume":"1","author":"Imran","year":"2024","journal-title":"Dev. Medico-Life-Sci."},{"key":"10.1016\/j.micpath.2026.108503_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139037","article-title":"Characterization of Helicobacter pylori immunoreactive proteins NusB, isoprenyl transferase, and hypothetical protein via immunoproteomics and molecular modeling approaches","volume":"291","author":"Shah","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2026.108503_bib97","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/antibiotics14050503","article-title":"Essential oils for biofilm control: mechanisms, synergies, and translational challenges in the era of antimicrobial resistance","volume":"14","author":"Touati","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108503_bib98","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12602-024-10348-7","article-title":"Probiotics as a therapeutic approach for non-infectious gastric ulcer management: a comprehensive review","volume":"17","author":"Mal","year":"2025","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.micpath.2026.108503_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13020-025-01093-2","article-title":"Plant-derived extracts or compounds for Helicobacter-associated gastritis: a systematic review of their anti-Helicobacter activity and anti-inflammatory effect in animal experiments","volume":"20","author":"Chen","year":"2025","journal-title":"Chin. Med."},{"issue":"2","key":"10.1016\/j.micpath.2026.108503_bib100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.NPR.0000000000000402","article-title":"Next-generation approaches in treatment of Helicobacter pylori infection in adults","volume":"51","author":"Churaman","year":"2026","journal-title":"Nurs. Pract."},{"key":"10.1016\/j.micpath.2026.108503_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1750216","article-title":"In Vitro study on anti-helicobacter pylori effects of DL-3-n-butylphthalide-loaded silk fibroin nanoparticles","volume":"16","author":"Cui","year":"2026","journal-title":"Front. Microbiol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026002299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026002299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T11:09:28Z","timestamp":1779016168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026002299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":101,"alternative-id":["S0882401026002299"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108503","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combating antimicrobial-resistant Helicobacter pylori infection using nanotechnology- an advancement in gastrointestinal disease treatment","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108503"}}